Brief: Argent Biopharma Ltd Says Ordinary Shares Approved To Trade On The Otcqb Venture Market In The United States
07/05/2024 02:18
May 7 (Reuters) - Argent BioPharma Ltd RGT.AX :
* ORDINARY SHARES APPROVED TO TRADE ON THE OTCQB VENTURE
MARKET
IN THE UNITED STATES
* SHARES COMMENCED TRADING AT THE MARKET OPEN ON 2 MAY 2024
Further company coverage: RGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program